OTCMKTS:LHDXQ Lucira Health (LHDXQ) Stock Price, News & Analysis → DON’T buy gold until you read this (From Sasco Gold LLC) (Ad) Free LHDXQ Stock Alerts $0.0001 +0.00 (+∞) (As of 10/4/2023) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$1.45Volume20,900 shsAverage Volume7.18 million shsMarket Capitalization$4,060.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisInsider TradesStock AnalysisInsider Trades Get Lucira Health alerts: Email Address Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. About Lucira Health Stock (OTCMKTS:LHDXQ)Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More LHDXQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LHDXQ Stock News HeadlinesSeptember 20, 2023 | msn.comU.S. govt. to restart program to ship free at-home COVID testsAugust 3, 2023 | forbes.comBest Senior Dating Sites Of 2023April 28, 2023 | benzinga.comRemember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction BidApril 20, 2023 | marketwatch.com8-K: Lucira Health, Inc.April 11, 2023 | bizjournals.comBankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to PfizerApril 7, 2023 | bizjournals.comPfizer to buy Covid-flu test developer Lucira Health out of bankruptcy courtApril 6, 2023 | wsj.comFirm Retention Summary: Lucira Health Inc.March 29, 2023 | marketwatch.comLucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale ProcessMarch 20, 2023 | investing.comLucira Health Inc (LHDXQ)March 18, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 17, 2023 | seekingalpha.comLHDXQ Lucira Health, Inc.March 10, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 8, 2023 | bizjournals.comCovid-flu test fell short of number of flu samples, FDA says in explaining delayMarch 8, 2023 | bizjournals.comFDA fires back at claims of long delay in approving combined Covid-flu testMarch 7, 2023 | finance.yahoo.comUPDATE 1-Lucira's home test for flu and COVID-19 gets U.S. FDA nod for OTC useMarch 7, 2023 | finance.yahoo.comFDA Approval Brings Some Good News For Bankrupt Lucira HealthMarch 3, 2023 | investorplace.comWhy Is Lucira Health (LHDX) Stock Down 14% Today?February 28, 2023 | benzinga.comShort Volatility Alert: Lucira Health IncFebruary 28, 2023 | msn.comLucira Soars on FDA Approval of COVID-19 and Flu TestFebruary 27, 2023 | finance.yahoo.comLucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy FilingFebruary 27, 2023 | msn.comLucira Health is Soaring Monday: Here Are The DetailsFebruary 27, 2023 | rttnews.comFDA Authorizes First At-Home Test To Detect Flu And COVID-19 February 24, 2023 | bizjournals.comDelay with Covid-flu test sent East Bay company to Chapter 11. Regulators OK it — two days laterFebruary 24, 2023 | finance.yahoo.comLucira stock more than doubles after hours on FDA OK for COVID-19, flu testFebruary 24, 2023 | seekingalpha.comLucira Health to sell business and file Chapter 11 bankruptcy; shares down 7%See More Headlines Receive LHDXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today6/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:LHDXQ CUSIPN/A CIK1652724 Webwww.lucirahealth.com Phone510-350-8071FaxN/AEmployees221Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$93.06 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book0.00Miscellaneous Outstanding Shares40,600,000Free Float28,257,000Market Cap$4,060.00 OptionableNot Optionable Beta2.60 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesGreg ChodaczekInvestor RelationsDr. Nadine Greiner Ph.D.Chief HR OfficerKey CompetitorsGlobal WholeHealth PartnersOTCMKTS:GWHPNavidea BiopharmaceuticalsNYSE:NAVBFluoroPharma MedicalOTCMKTS:FPMIBG MedicineOTCMKTS:BGMDHemagen DiagnosticsOTCMKTS:HMGNView All Competitors LHDXQ Stock Analysis - Frequently Asked Questions How have LHDXQ shares performed in 2024? Lucira Health's stock was trading at $0.0001 at the beginning of the year. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here. How were Lucira Health's earnings last quarter? Lucira Health, Inc. (OTCMKTS:LHDXQ) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($0.51) by $0.04. The company earned $14.98 million during the quarter, compared to analysts' expectations of $18 million. How do I buy shares of Lucira Health? Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LHDXQ) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucira Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucira Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.